Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...

J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog ... To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Our writer can see the appeal of this recently popular dividend stock from the FTSE 100 index. But will he buy it for his own ...

This writer considers how long it would take an investor to reach a seven-figure sum by maxing out their Stocks and Shares ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on NVO.

U.S. tariffs have thrown the market into disarray, leading to massive sell-offs. On the other hand, some investors have ...

A US-China trade deal that includes tariff cuts sent US stock markets soaring. Australia's stock market closed higher in ...

Eli Lilly announced that its obesity therapy Zepbound delivered superior outcomes versus Novo Nordisk’s Wegovy across five ...

The drugmaker's approved treatment, Kisunla (donanemab), works by binding to deposited amyloid plaque in the brain. Its phase 3 Alzheimer's asset, remternetug, also binds to amyloid plaques. It is ...